LNC
ABBV icon

Lincoln National Corp’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-83,505
Closed -$15.2M 26
2024
Q1
$15.2M Buy
83,505
+3,191
+4% +$581K 0.24% 68
2023
Q4
$12.4M Buy
80,314
+3,354
+4% +$520K 0.22% 67
2023
Q3
$11.5M Buy
76,960
+1,692
+2% +$252K 0.23% 63
2023
Q2
$10.1M Buy
75,268
+2,215
+3% +$298K 0.2% 69
2023
Q1
$11.6M Buy
73,053
+4,907
+7% +$782K 0.24% 57
2022
Q4
$11M Buy
68,146
+1,873
+3% +$303K 0.25% 54
2022
Q3
$8.89M Buy
66,273
+8,937
+16% +$1.2M 0.22% 63
2022
Q2
$8.78M Sell
57,336
-3,147
-5% -$482K 0.21% 69
2022
Q1
$9.81M Sell
60,483
-542
-0.9% -$87.9K 0.2% 68
2021
Q4
$8.26M Buy
61,025
+2,516
+4% +$341K 0.17% 73
2021
Q3
$6.31M Buy
58,509
+2,528
+5% +$273K 0.14% 80
2021
Q2
$6.31M Buy
55,981
+2,943
+6% +$332K 0.14% 82
2021
Q1
$5.74M Buy
53,038
+5,965
+13% +$646K 0.14% 80
2020
Q4
$5.04M Buy
47,073
+5,145
+12% +$551K 0.13% 81
2020
Q3
$3.67M Buy
41,928
+1,454
+4% +$127K 0.11% 103
2020
Q2
$3.97M Buy
40,474
+5,125
+14% +$503K 0.13% 88
2020
Q1
$2.69M Sell
35,349
-4,608
-12% -$351K 0.1% 104
2019
Q4
$3.54M Buy
39,957
+6,220
+18% +$551K 0.11% 94
2019
Q3
$2.56M Buy
33,737
+5,030
+18% +$381K 0.09% 111
2019
Q2
$2.09M Buy
28,707
+5,863
+26% +$426K 0.08% 120
2019
Q1
$1.84M Buy
22,844
+2,055
+10% +$166K 0.08% 118
2018
Q4
$1.92M Buy
20,789
+1,819
+10% +$168K 0.09% 104
2018
Q3
$1.79M Sell
18,970
-7,079
-27% -$669K 0.06% 114
2018
Q2
$2.41M Sell
26,049
-802
-3% -$74.3K 0.09% 81
2018
Q1
$2.54M Sell
26,851
-13,298
-33% -$1.26M 0.09% 82
2017
Q4
$3.88M Buy
40,149
+19,763
+97% +$1.91M 0.12% 88
2017
Q3
$1.81M Buy
20,386
+447
+2% +$39.7K 0.08% 93
2017
Q2
$1.45M Sell
19,939
-566
-3% -$41K 0.07% 94
2017
Q1
$1.34M Sell
20,505
-466
-2% -$30.4K 0.07% 95
2016
Q4
$1.31M Buy
20,971
+860
+4% +$53.8K 0.07% 106
2016
Q3
$1.27M Buy
20,111
+898
+5% +$56.7K 0.07% 108
2016
Q2
$1.19M Buy
19,213
+551
+3% +$34.1K 0.07% 107
2016
Q1
$1.07M Buy
18,662
+9,195
+97% +$525K 0.08% 103
2015
Q4
$527K Buy
+9,467
New +$527K 0.04% 117